Cresp 25 Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Overview Cresp 25 Injection
Darbepoetin alfa 25 mcg injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation to increase red blood cell production. This medication requires careful administration due to potential serious adverse reactions; expert medical supervision is essential. Strict adherence to physician instructions is mandatory. Administration occurs under healthcare professional oversight. Common side effects include abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral edema. Report symptoms of severe hypertension—intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests monitoring electrolyte (e.g., potassium) levels, hemoglobin, and blood cell counts will be conducted. Discontinue use and seek medical advice if experiencing shortness of breath or a skin eruption. Prior to commencing treatment, inform your doctor of any pre-existing heart disease, hypertension, seizure history, or stroke. Pregnant, breastfeeding, intending to conceive, or nursing individuals should discuss the medication's safety with their physician.
Uses of Cresp 25 Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Cresp 25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cresp 25 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Cresp 25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cresp 25 Injection works:
Cresp 25 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by prompting increased red blood cell generation within the bone marrow, the blood-cell-producing tissue found inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cresp 25 Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cresp 25 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Cresp 25 Injection while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Cresp 25 Injection.
KidneySAFE IF PRESCRIBED
Cresp 25 Injection poses no safety concerns for individuals with renal impairment, and no alteration of the Cresp 25 Injection dosage is necessary.
LiverCAUTION
For individuals with hepatic impairment, administering Cresp 25 Injection requires careful consideration. Dosage modification of Cresp 25 Injection might be necessary. Physician consultation is advised.
What if you forget to take Cresp 25 Injection :
Should you forget a Cresp 25 Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cresp 25 Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Erythropoietin-stimulating drug |








